AXA Venture Partners, a venture capital firm investing in high-growth technology companies, completed the first closing of the second vintage of its Early Stage Fund (AVP Early Stage II) with $150m (€130m).
The new fund will focus on North America, Europe & Israel and will aim to invest in outstanding technology businesses, pre and early revenue, in enterprise SaaS, consumer platform and SME solutions, with particular focus on fintech and digital health.
AVP Early Stage II will write initial checks up to $6m and will support entrepreneurs by providing them business development opportunities with AXA and any other relevant corporations.
Led by Francois Robinet, Manish Agarwal, Alex Scherbakovsky, and Imran Akram, AXA Venture Partners is a venture capital fund investing in high-growth, technology enabled companies. Since 2015, the firm has supported more than 40 companies in the Early and Growth stages with a focus on the following verticals: digital health,
cyber-security, enterprise software, artificial intelligence, fintech/insurtech, most recently including investments in early stage companies such as Hackajob, K4Connect, Futurae and growth stage companies like Zenjob, Phenom People and Happytal.
AVP has $600m of assets under management through Early Stage Fund, Growth Stage Fund and Fund of Funds. To date, it has invested in 40 Early and Growth equity deals and 6 fund investments.
The team operates globally in offices in San Francisco, New York, London, Paris and Hong Kong.